{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:21:08Z","timestamp":1769581268768,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T00:00:00Z","timestamp":1589414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T00:00:00Z","timestamp":1589414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s12325-020-01359-1","type":"journal-article","created":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T15:50:33Z","timestamp":1589471433000},"page":"2748-2762","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pattern of Laboratory Parameters and Management of Secondary Hyperparathyroidism in Countries of Europe, Asia, the Middle East, and North America"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8494-6252","authenticated-orcid":false,"given":"Mario","family":"Cozzolino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugeniy","family":"Shilov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Fukagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed M. G.","family":"Al-Ghamdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Pisoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Bieber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhadrish","family":"Vallabh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepa H.","family":"Chand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,14]]},"reference":[{"key":"1359_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4103\/1319-2442.124536","volume":"25","author":"M Al Rukhaimi","year":"2014","unstructured":"Al Rukhaimi M, Al Sahow A, Boobes Y, et al. Adaptation and implementation of the \"Kidney Disease: Improving Global Outcomes (KDIGO)\" guidelines for evaluation and management of mineral and bone disorders in chronic kidney disease for practice in the Middle East countries. Saudi J Kidney Dis Transpl. 2014;25:133\u201348.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"1359_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1258\/shorts.2012.011150","volume":"3","author":"AA Hassanien","year":"2012","unstructured":"Hassanien AA, Al-Shaikh F, Vamos EP, Yadegarfar G, Majeed A. Epidemiology of end-stage renal disease in the countries of the Gulf Cooperation Council: a systematic review. JRSM Short Rep. 2012;3:38.","journal-title":"JRSM Short Rep"},{"key":"1359_CR3","doi-asserted-by":"crossref","first-page":"c120","DOI":"10.1159\/000345149","volume":"121","author":"YM Farag","year":"2012","unstructured":"Farag YM, Kari JA, Singh AK. Chronic kidney disease in the Arab world: a call for action. Nephron Clin Pract. 2012;121:c120\u2013c123123.","journal-title":"Nephron Clin Pract"},{"key":"1359_CR4","doi-asserted-by":"publisher","first-page":"e010832","DOI":"10.1136\/bmjopen-2015-010832","volume":"6","author":"S Al Shamsi","year":"2016","unstructured":"Al Shamsi S, Al Dhanhani A, Sheek-Hussein MM, Bakoush O. Provision of care for chronic kidney disease by non-nephrologists in a developing nation: a national survey. BMJ Open. 2016;6:e010832.","journal-title":"BMJ Open"},{"key":"1359_CR5","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","volume":"379","author":"L Zhang","year":"2012","unstructured":"Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379:815\u201322.","journal-title":"Lancet"},{"key":"1359_CR6","volume-title":"2017 USRDS annual data report: epidemiology of kidney disease in the United States","author":"United States Renal Data System","year":"2017","unstructured":"United States Renal Data System. 2017 USRDS annual data report: epidemiology of kidney disease in the United States. MD: Bethesda; 2017."},{"key":"1359_CR7","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","volume":"382","author":"V Jha","year":"2013","unstructured":"Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260\u201372.","journal-title":"Lancet"},{"key":"1359_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4239\/wjd.v7.i8.165","volume":"7","author":"B Abuyassin","year":"2016","unstructured":"Abuyassin B, Laher I. Diabetes epidemic sweeping the Arab world. World J Diabetes. 2016;7:165\u201374.","journal-title":"World J Diabetes"},{"key":"1359_CR9","doi-asserted-by":"publisher","first-page":"e65938","DOI":"10.1371\/journal.pone.0065938","volume":"8","author":"Y Gao","year":"2013","unstructured":"Gao Y, Chen G, Tian H, et al. Prevalence of hypertension in China: a cross-sectional study. PLoS One. 2013;8:e65938.","journal-title":"PLoS One"},{"key":"1359_CR10","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","volume":"385","author":"T Liyanage","year":"2015","unstructured":"Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385:1975\u201382.","journal-title":"Lancet"},{"key":"1359_CR11","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2215\/CJN.06040710","volume":"6","author":"J Cunningham","year":"2011","unstructured":"Cunningham J, Locatelli F, Rodriguez M. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol. 2011;6:913\u201321.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1359_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/sj.ki.5002009","volume":"71","author":"A Levin","year":"2007","unstructured":"Levin A, Bakris GL, Molitch M, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007;71:31\u20138.","journal-title":"Kidney Int"},{"key":"1359_CR13","doi-asserted-by":"publisher","first-page":"184321","DOI":"10.1155\/2015\/184321","volume":"2015","author":"E Hedgeman","year":"2015","unstructured":"Hedgeman E, Lipworth L, Lowe K, Saran R, Do T, Fryzek J. International burden of chronic kidney disease and secondary hyperparathyroidism: a systematic review of the literature and available data. Int J Nephrol. 2015;2015:184321.","journal-title":"Int J Nephrol"},{"key":"1359_CR14","unstructured":"Kidney Disease: Improving Global Outcomes Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2009:S1\u2013130"},{"key":"1359_CR15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1525-139X.2009.00581.x","volume":"22","author":"M Rodriguez","year":"2009","unstructured":"Rodriguez M, Lorenzo V. Parathyroid hormone, a uremic toxin. Semin Dial. 2009;22:363\u20138.","journal-title":"Semin Dial"},{"key":"1359_CR16","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","volume":"15","author":"GA Block","year":"2004","unstructured":"Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15:2208\u201318.","journal-title":"J Am Soc Nephrol"},{"key":"1359_CR17","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","volume":"12","author":"SK Ganesh","year":"2001","unstructured":"Ganesh SK, Stack AG, Levin NW, Hylbert-Shearon T, Port FK. Association of elevated serum PO4, Ca \u00d7 PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol. 2001;12:2131\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"1359_CR18","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1046\/j.1523-1755.2000.07413.x","volume":"57","author":"EW Young","year":"2000","unstructured":"Young EW, Goodkin DA, Mapes DL, et al. The Dialysis Outcomes and Practice Patterns Study (DOPPS): an international hemodialysis study. Kidney Int. 2000;57:S74\u2013S81.","journal-title":"Kidney Int"},{"key":"1359_CR19","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.2215\/CJN.04940512","volume":"7","author":"BM Robinson","year":"2012","unstructured":"Robinson BM, Bieber B, Pisoni RL, Port FK. Dialysis Outcomes and Practice Patterns Study (DOPPS): its strengths, limitations, and role in informing practices and policies. Clin J Am Soc Nephrol. 2012;7:1897\u2013905.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1359_CR20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","volume":"52","author":"F Tentori","year":"2008","unstructured":"Tentori F, Blayney MJ, Albert JM, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2008;52:519\u201330.","journal-title":"Am J Kidney Dis"},{"key":"1359_CR21","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/S0272-6386(00)70064-3","volume":"35","author":"GA Block","year":"2000","unstructured":"Block GA, Port FK. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis. 2000;35:1226\u2013377.","journal-title":"Am J Kidney Dis"},{"key":"1359_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2215\/CJN.12941213","volume":"10","author":"F Tentori","year":"2015","unstructured":"Tentori F, Wang M, Bieber BA, et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol. 2015;10:98\u2013109.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1359_CR23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4103\/1319-2442.194902","volume":"27","author":"I Al Salmi","year":"2016","unstructured":"Al Salmi I, AlRukhaimi M, AlSahow A, et al. Mineral bone disorder and its management among hemodialysis patients in the Gulf Cooperation Council: initial findings from the Dialysis Outcomes and Practice Patterns Study (2012\u20132015). Saudi J Kidney Dis Transpl. 2016;27:62\u201380.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"1359_CR24","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/hdi.12503","volume":"21","author":"B Bikbov","year":"2017","unstructured":"Bikbov B, Bieber B, Andrusev A, et al. Hemodialysis practice patterns in the Russia Dialysis Outcomes and Practice Patterns Study (DOPPS), with international comparisons. Hemodial Int. 2017;21:393\u2013408.","journal-title":"Hemodial Int"},{"key":"1359_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0272-6386(04)01099-6","volume":"44","author":"RL Pisoni","year":"2004","unstructured":"Pisoni RL, Gillespie BW, Dickinson DM, Chen K, Kutner MH, Wolfe RA. The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology. Am J Kidney Dis. 2004;44:7\u201315.","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"1359_CR26","first-page":"1","volume":"2017","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group","year":"2017","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2017;2017(7):1\u201359.","journal-title":"Kidney Int Suppl"},{"key":"1359_CR27","first-page":"S1","volume":"42","author":"National Kidney Foundation","year":"2003","unstructured":"National Kidney Foundation. K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42:S1\u2013201.","journal-title":"Am J Kidney Dis"},{"key":"1359_CR28","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12882-018-1037-8","volume":"19","author":"JO Burton","year":"2018","unstructured":"Burton JO, Goldsmith DJ, Ruddock N, Shroff R, Wan M. Renal association commentary on the KDIGO (2017) clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of CKD-MBD. BMC Nephrol. 2018;19:240.","journal-title":"BMC Nephrol"},{"key":"1359_CR29","doi-asserted-by":"publisher","first-page":"e0202417","DOI":"10.1371\/journal.pone.0202417","volume":"13","author":"S Borrelli","year":"2018","unstructured":"Borrelli S, Chiodini P, De Nicola L, et al. Prognosis and determinants of serum PTH changes over time in 1\u20135 CKD stage patients followed in tertiary care. PLoS One. 2018;13:e0202417.","journal-title":"PLoS One"},{"key":"1359_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000490769","volume":"140","author":"M Cozzolino","year":"2018","unstructured":"Cozzolino M, Bolasco P, Ronco C, et al. Clinical management of chronic kidney disease patients in Italy: results from the IRIDE Study. Nephron. 2018;140:39\u201347.","journal-title":"Nephron"},{"key":"1359_CR31","first-page":"243","volume":"34","author":"A Martinez-Castelao","year":"2014","unstructured":"Martinez-Castelao A, Gorriz JL, Bover J, et al. Consensus document for the detection and management of chronic kidney disease. Nefrologia. 2014;34:243\u201362.","journal-title":"Nefrologia"},{"key":"1359_CR32","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1053\/j.ajkd.2010.02.340","volume":"55","author":"K Uhlig","year":"2010","unstructured":"Uhlig K, Berns JS, Kestenbaum B, et al. KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the diagnosis, evaluation, and treatment of CKD-mineral and bone disorder (CKD-MBD). Am J Kidney Dis. 2010;55:773\u201399.","journal-title":"Am J Kidney Dis"},{"key":"1359_CR33","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","volume":"31","author":"GA Block","year":"1998","unstructured":"Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium \u00d7 phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998;31:607\u201317.","journal-title":"Am J Kidney Dis"},{"key":"1359_CR34","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1093\/ndt\/gfs598","volume":"28","author":"J Li","year":"2013","unstructured":"Li J, Molnar MZ, Zaritsky JJ, et al. Correlates of parathyroid hormone concentration in hemodialysis patients. Nephrol Dial Transplant. 2013;28:1516\u201325.","journal-title":"Nephrol Dial Transplant"},{"key":"1359_CR35","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/1744-9987.12058","volume":"17","author":"M Fukagawa","year":"2013","unstructured":"Fukagawa M, Yokoyama K, Koiwa F, et al. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial. 2013;17:247\u201388.","journal-title":"Ther Apher Dial"},{"key":"1359_CR36","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.2147\/PPA.S145648","volume":"12","author":"EM Umeukeje","year":"2018","unstructured":"Umeukeje EM, Mixon AS, Cavanaugh KL. Phosphate-control adherence in hemodialysis patients: current perspectives. Patient Prefer Adherence. 2018;12:1175\u201391.","journal-title":"Patient Prefer Adherence"},{"key":"1359_CR37","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2215\/CJN.00290109","volume":"4","author":"YW Chiu","year":"2009","unstructured":"Chiu YW, Teitelbaum I, Misra M, de Leon EM, Adzize T, Mehrotra R. Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol. 2009;4:1089\u201396.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1359_CR38","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1471-2369-13-116","volume":"13","author":"X Kong","year":"2012","unstructured":"Kong X, Zhang L, Zhang L, et al. Mineral and bone disorder in Chinese dialysis patients: a multicenter study. BMC Nephrol. 2012;13:116.","journal-title":"BMC Nephrol"},{"key":"1359_CR39","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/sj.ki.5002287","volume":"74","author":"WG Goodman","year":"2008","unstructured":"Goodman WG, Quarles LD. Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics. Kidney Int. 2008;74:276\u201388.","journal-title":"Kidney Int"},{"key":"1359_CR40","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1136\/bmj.39527.628322.AD","volume":"336","author":"A Benjamin","year":"2008","unstructured":"Benjamin A. Audit: how to do it in practice. BMJ. 2008;336:1241\u20135.","journal-title":"BMJ"},{"key":"1359_CR41","first-page":"93","volume":"21","author":"MZ Souqiyyeh","year":"2010","unstructured":"Souqiyyeh MZ, Shaheen FA. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Saudi J Kidney Dis Transpl. 2010;21:93\u2013101.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"1359_CR42","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.4103\/1319-2442.144249","volume":"25","author":"A Karkar","year":"2014","unstructured":"Karkar A, Sinha AK, Abdelrahman M, et al. Trends of elevated parathormone serum titers in hemodialysis patients on intensive therapy for bone disease: a multicenter study. Saudi J Kidney Dis Transpl. 2014;25:1166\u201377.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"1359_CR43","unstructured":"Nephrology Association, Scientific Society of Nephrology of Russia. Mineral and bone disturbances in chronic kidney disease (MBD-CKD) [in Russian]. https:\/\/nonr.ru\/?page_id=3178. Accessed Sep 6, 2019"},{"key":"1359_CR44","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12882-018-1056-5","volume":"19","author":"S Yamamoto","year":"2018","unstructured":"Yamamoto S, Karaboyas A, Komaba H, et al. Mineral and bone disorder management in hemodialysis patients: comparing PTH control practices in Japan with Europe and North America: the Dialysis Outcomes and Practice Patterns Study (DOPPS). BMC Nephrol. 2018;19:253.","journal-title":"BMC Nephrol"},{"key":"1359_CR45","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.2215\/CJN.13091216","volume":"12","author":"H Komaba","year":"2017","unstructured":"Komaba H, Wang M, Taniguchi M, et al. Initiation of sevelamer and mortality among hemodialysis patients treated with calcium-based phosphate binders. Clin J Am Soc Nephrol. 2017;12:1489\u201397.","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01359-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-020-01359-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01359-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T19:10:19Z","timestamp":1666552219000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-020-01359-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,14]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1359"],"URL":"https:\/\/doi.org\/10.1007\/s12325-020-01359-1","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,14]]},"assertion":[{"value":"18 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}